
|Poll|August 22, 2019
Poll: Is DRE still a relevant tool in the management of prostate cancer?
Do you feel that DRE is still a relevant tool in the management of prostate cancer? Take our latest poll and let us know.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
3
Doublet or triplet? Urologists weighs in on mCSPC options
4
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
5










